Page last updated: 2024-11-04

sumatriptan and Miosis

sumatriptan has been researched along with Miosis in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Miosis: Pupillary constriction. This may result from congenital absence of the dilatator pupillary muscle, defective sympathetic innervation, or irritation of the CONJUNCTIVA or CORNEA.

Research Excerpts

ExcerptRelevanceReference
"Buspirone (5, 10, and 20 mg) caused a dose-dependent miosis."9.08Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. ( Alessandri, M; Fanciullacci, M; Geppetti, P; Sicuteri, R, 1995)
"Buspirone (5, 10, and 20 mg) caused a dose-dependent miosis."5.08Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. ( Alessandri, M; Fanciullacci, M; Geppetti, P; Sicuteri, R, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fanciullacci, M1
Sicuteri, R1
Alessandri, M1
Geppetti, P1

Trials

1 trial available for sumatriptan and Miosis

ArticleYear
Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.
    Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:3

    Topics: Administration, Oral; Adult; Analysis of Variance; Buspirone; Dose-Response Relationship, Drug; Doub

1995